A Medscape Live Event at the 37th Annual EAU Congress SUNDAY, 3 JULY 2022 | 17:45 - 19:15 CETExpert Guidance in Non-Muscle Invasive Bladder Cancer: Applying the Latest Recommendations to Clinical Practice

What is BC Care?

Instillation therapies for bladder cancer (BC) have a long tradition for our company. With BCG-medac and Mitomycin we offer the complete first-line arsenal for adjuvant treatment of non-muscle invasive bladder tumours of all risk classes. We have developed the first closed instillation system equipped as standard with all our designated bladder cancer drugs. Our service and competence is highly appreciated by urologists from all over the world.

BC CARE by medac stands for all this. We care about giving bladder cancer patients the optimal therapies. We care about personal safety of nurses, urologists and pharmacists.

We care about healthcare.

We care about Bladder Cancer

Despite being one of the most prevalent malignant diseases bladder cancer has a low public awareness. Informing patients and healthcare professionals alike is an important step in battling this disease.  

What is bladder cancer?

To understand bladder cancer , it helps to know about the normal structure and function of the bladder.

What are the risk factors of bladder cancer?

A risk factor is anything that changes your chance of getting a disease such as cancer.

What are the signs and symptoms of bladder cancer?

Bladder cancer can often be found early because it causes blood in the urine or other urinary symptoms.

How is bladder cancer diagnosed?

Bladder cancer is often found because of signs and symptoms a person is having, or it might be found because of lab tests a person is getting for another reason.

How is bladder cancer treated?

The treatment for bladder cancer depends on its location and spread. Cancer of the bladder that has not invaded the muscle may be surgically removed through the urethra using an endoscope.


We care about Healthcare Professionals

Personal safety of nurses, urologists and pharmacists is our particular concern. Therefore all our designated bladder cancer drugs are equipped with a closed instillation system.

Leider verwenden Sie einen veralteten Browser.
Unser Internetauftritt wurde auf Basis zeitgemäßer und sicherer Technologien entwickelt. Daher kann es bei der Nutzung eines veralteten Browsers zu Problemen bei der Darstellung und den Funktionalitäten kommen. Wir empfehlen Ihnen, einen anderen aktuellen und kostenlosen Browser zu nutzen:
Mozilla Firefox
Google Chrome
Microsoft Edge


We use technically necessary cookies for the operation of the website. Other cookies are only set with your consent. We use these to statistically analyse the use of the website (location, time, end device, referrer URL). We also share information about the use of the website with our provider Google LLC. We have also integrated videos into our website via the provider Vimeo, a video hosting platform. The service provider is Vimeo Inc. Both providers may combine this information with other data. Your data may also be transferred to the USA. The USA (and other non-EEA countries) do not offer a level of data protection comparable to the EU; for example, government agencies can access data without any reason. However, both Google LLC. and Vimeo Inc. are committed to data protection-compliant processing with the EU standard contractual clauses.
You can revoke your consent to cookies and data transfer at any time with effect for the future. You can find more information in our privacy policy.

These cookies help making a website usable by enabling basic functions like page navigation and access to secure areas of the website. The website cannot function properly without these cookies.

These cookies help website owners to understand how visitors interact with websites by collecting and reporting information anonymously. With this information we can constantly improve the experience we offer on our website.

These cookies are used to track visitors across websites. The intention is to display ads that are relevant and engaging for the individual user and thereby more valuable for publishers and third party advertisers.